FT
Insider
Frank Torti
President and Vant ChairFrank Torti (President and Vant Chair) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Roivant Sciences Ltd. (ROIV). The largest single filing was $82.0M of ROIV (3,000,000 sh across 3 lots, as filed), executed Feb 19.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$82.0M
shares × price, as filed
Last traded
Feb 23
Filed Feb 23
Median ADV $222.0M across their filed names
Open performance→Volume by month
Buys $0
Sells $82.0M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
ROIVRecent filings
ROIVSALE
Roivant Sciences Ltd.
View filing →
$82.0M3,000,000 sh across 3 lots
Exec Feb 19
Filed Feb 23 · 5:30 PM ET